The Pharmacy on the Label Doesn't Exist: Counterfeit Tirzepatide and How to Check Yours
The FDA says some fraudulent GLP-1 vials name a compounding pharmacy that isn't real — or a real one that never touched the product. The label, the one thing you're supposed to be able to trust, is the con. Here's how to check it in five minutes.
In my pharmacy years, the label on a vial was the end of an argument. It told you who made the medicine, so if something ever went wrong, there was a real, licensed, findable somebody standing behind it. That accountability — not the sticker itself, the traceability the sticker represents — is the entire safety system in one small rectangle. So the thing I want to walk you through today genuinely rattled me, because it attacks that rectangle directly.
What the FDA is actually seeing
The FDA has been blunt about it. In its consumer guidance on unapproved GLP-1 drugs, the agency writes that it “is aware of fraudulent compounded semaglutide and tirzepatide marketed in the U.S. that contain false information on the product label. In some cases, the compounding pharmacies identified on the labels of the products do not exist.” In other cases, per the same FDA guidance, the label carries the name of a real, licensed pharmacy — one that, based on what the FDA has gathered, never compounded the product at all.
Sit with that for a second, because it's worse than a bad batch. A recall is a system working: a named pharmacy finds a problem and pulls its product. This is the opposite — a vial engineered so that if it hurts you, there's no one to trace, because the name on it was fiction from the start. The FDA's plain warning about counterfeits is that they “could contain the wrong ingredients, contain too little, too much or no active ingredient at all or other harmful ingredients.” You would be dosing yourself with a question mark and a fake return address.
This isn't only a shady-corner-of-the-internet problem
The easy assumption is that this only touches people buying “research use only” vials off social media. Those buyers are absolutely getting hit — the Partnership for Safe Medicines has tracked Americans buying directly from unregistered foreign factories, and in April 2026 authorities in India seized suspected fake Mounjaro pens built from raw materials ordered off a wholesale website. But the counterfeit problem has also, at moments, reached the legitimate chain. The FDA has announced multiple seizures of counterfeit Ozempic found within the U.S. drug supply chain, and, per Partnership for Safe Medicines, individual pharmacies — including one flagged by the Arkansas Board of Pharmacy — have quarantined fake pens found sitting in their own stock.
I'm not telling you this to make you afraid of your medicine cabinet. The overwhelming majority of prescriptions filled by licensed U.S. pharmacies are exactly what they say they are. I'm telling you because the counterfeiters' single favorite trick — a convincing but fake pharmacy name — is also the single easiest thing for you to check. The con has a weak spot, and it happens to be right on the label.
Why a fake pharmacy name is the whole game
Think about what a counterfeiter needs. The powder is cheap. The vial is cheap. The printed label is cheap. The one thing they cannot cheaply manufacture is legitimacy — a licensed pharmacy that a state board will confirm actually exists, actually holds a license in good standing, and actually made this. So they fake it. They invent a pharmacy, or borrow the name of a real one, and bet that you'll never pick up the phone to check. That bet is the business model. Refusing to take that bet is your defense.
This is checklist item number two, the one I keep coming back to: a trustworthy operation names the licensed pharmacy that fills your prescription, and you can verify that license yourself. Counterfeiters fail that test on contact, because the whole point of the fake name is that it can't survive a lookup.
How to check the pharmacy on your label in five minutes
You don't need a pharmacy background for any of this. You need the name on the vial and about five minutes.
- Get the pharmacy's name and state — before you buy, in writing. A legitimate telehealth or provider will tell you which licensed compounding pharmacy fills your script: name, city, state. If they dodge, or the only “pharmacy” is the website's own brand, stop there. That evasion is your answer.
- Verify the license with the state board. Every state pharmacy board keeps a public license lookup. Search the pharmacy's name in the state it claims to operate in. No record, or a name that doesn't match, is a hard stop. (Your state board is also who you tell if something looks wrong — boards act on exactly these tips.)
- Cross-check with NABP. The National Association of Boards of Pharmacy runs a consumer verification tool at Safe.Pharmacy to help you confirm whether an online pharmacy is operating legitimately. It's built for exactly this moment.
- Look at the vial you already have. Real product has a lot number and a beyond-use date, and it arrives shipped the way a temperature-sensitive medication should be. Missing lot number, no dating, a label with typos, or a padded envelope with no cold pack are all reasons to call the prescriber before you inject anything.
If any single one of these comes up empty, don't use the product, and report it — to your state board of pharmacy and to the FDA. You are not being paranoid. You are doing the one check the counterfeiter was counting on you to skip.
Run the label through the checklist
The scariest counterfeit GLP-1s aren't the ones that look obviously fake — they're the ones with a clean, professional label naming a pharmacy that doesn't exist. That single lie is designed to erase accountability. It also happens to be the easiest lie to catch: get the pharmacy's name, verify the license with the state board and NABP, and check the vial for a lot number and proper shipping. A real pharmacy passes those checks in minutes. A fake one can't pass them at all — which is exactly why you run them.
Sources & further reading
- FDA: “FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss” — fraudulent labels naming pharmacies that don't exist (or real pharmacies that didn't make the product), and what counterfeit products may actually contain
- FDA: “FDA warns consumers not to use counterfeit Ozempic found in U.S. drug supply chain” — the seizures of counterfeit product found inside the legitimate supply chain
- Partnership for Safe Medicines: “Safety risks in the GLP-1 market, May 2026” — customs interceptions, the April 2026 fake-Mounjaro seizure in India, and pharmacy-level quarantines including one flagged by the Arkansas Board of Pharmacy
- NABP Safe.Pharmacy — the National Association of Boards of Pharmacy's consumer tool for checking whether an online pharmacy is legitimate
- Related: how tirzepatide online scams actually work, what whistleblowers say happened at a GLP-1 supplier, and my provider checklist
Medical disclaimer: The Compounded Brief is not a pharmacy, prescriber, or medical provider, and nothing here is medical advice. Compounded medications are not FDA-approved; obtain them only from a licensed compounding pharmacy after evaluation by a licensed provider. Talk to a licensed professional before starting, stopping, or changing any medication.